Crossmark

A novel GnRH antagonist protocol based on LH levels versus traditional flexible GnRH antagonist protocol in PCOS patients undergoing in vitro fertilization: study protocol for a randomized controlled, non-inferiority trial

Crossref DOI link: https://doi.org/10.1186/s13063-022-06586-1

Published Online: 2022-08-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liu, Shan

Lv, Ya-su

Han, Shuo

Liu, Minghui

Ma, Shuai

Ren, Haiying

Li, Yuan https://orcid.org/0000-0002-1683-6801
Funding

Funding for this research was provided by:

Capital Health Development Scientific Research Project (Independent Innovation, 2020-1-2039)

Beijing Health Promotion Foundation (2019-09-05)

2020 Fertility Research Program of Young and Middle-aged Physicians-China Health Promotion Foundation

Beijing Hospitals Authority Youth Programme (QML20200301)
License Information

Text and Data Mining valid from 2022-08-13

Version of Record valid from 2022-08-13
More Information

Article History

Received: 11 February 2022

Accepted: 22 July 2022

First Online: 13 August 2022

Declarations

:

: This trial has been approved by the Ethics Committee of Beijing Chaoyang Hospital affiliated to Capital Medical University (No: 2018-SCI-194). Written informed consent will be obtained from all participants. The study will be conducted following the principles outlined in the Declaration of Helsinki and its amendments and the Medical Research Involving Human Subjects Act and will adhere to Good Clinical Practices. The results of this trial will be disseminated through conference presentations and peer-reviewed scientific journals.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below